ADmit Therapeutics S.L. 

ADmit Test: an early Alzheimer’s Disease diagnosis test

OWNER

Marta Barrachina (See Profile)

Sector

Diagnostics

Stage

Development, market readiness, clinical trial

Country

Spain


Alzheimer's detection in mild cognitive impairment patients

Disruptive biomarkers non related with b-amyloid or tau

Predictive algorithm

This information is confidential, do not share or copy.

Under evaluation at least till: 13th November

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2019 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar